Water-Soluble Vitamin · Saturable Absorption · Antioxidant / Pro-Oxidant Duality

Vitamin C

An essential cofactor humans cannot synthesize for themselves — and one whose oral absorption has a hard ceiling most labels never mention, whose risks are sharply sex-specific, and whose highest-dose IV uses sit in the middle of a genuinely unresolved scientific debate.

Most often used for:
Immune Support Iron Absorption Collagen & Skin Antioxidant Defense High-Dose IV Therapy Carnitine Synthesis
~200mg Single-Dose Absorption Ceiling
2× Kidney Stone Risk in Men, ≥1g/day
2,000mg Tolerable Upper Intake Level
0% Stored in the Body (Water-Soluble)
Updated
RDA (Adults) 90mg men · 75mg women
Upper Limit 2,000mg/day
Primary Sources NIH ODS · PNAS · Cochrane · JAMA
Essential Cofactor · Saturable Absorption · Sex-Specific Safety Profile

Biological Overview

Vitamin C (L-ascorbic acid) is a water-soluble vitamin and enzymatic cofactor that the human body cannot manufacture on its own. Most mammals synthesize their own vitamin C from glucose, but humans, along with other primates and a handful of other species, carry a nonfunctional version of the gene (GULO) for the final enzyme in that pathway [26] — making dietary intake strictly necessary, the same vulnerability behind scurvy. Vitamin C serves as a cofactor for the enzymes that hydroxylate collagen (essential for connective tissue, skin, and wound healing), acts as a direct water-soluble antioxidant, and chemically reduces dietary iron into a form the gut absorbs far more easily. Its oral absorption, however, is not unlimited: the same intestinal transporters that bring it into the body become saturated at modest doses, a ceiling discussed in detail in the Absorption Guide below. [1]

Endogenous SynthesisNone (GULO gene nonfunctional)
Single-Dose Bioavailability~100% at ≤200mg, declining above
Storage in the BodyNone — water-soluble, excreted
Strongest EvidenceIron Absorption · Collagen Synthesis
Supplement Classification

Overview & Classification

Chemical Class
Water-soluble vitamin (six-carbon lactone)
Common Forms
Ascorbic acid, buffered ascorbates, liposomal, IV
RDA, Adult Men
90 mg/day
RDA, Adult Women
75 mg/day
Smokers
+35 mg/day above RDA
Pregnancy / Lactation
85 mg / 120 mg per day
Tolerable Upper Intake Level
2,000 mg/day
Half-Life, Whole-Body Pool
~8–40 days, varies with body stores
Plain-Language Benefits

Vitamin C Benefits

Some of vitamin C's roles are textbook-solid. Others — especially around immunity and high-dose therapy — are genuinely more contested than popular belief suggests, and both are stated honestly below.

🤧
Immune Support & Common Cold Subgroup-Dependent
No general benefit, except under physical stress
  • The Cochrane review pooling over 10,000 general-population participants found regular vitamin C supplementation did not reduce the risk of catching a cold (relative risk 0.97, not statistically significant). [11]
  • It did modestly shorten cold duration — about 8% in adults and 14% in children — and reduced symptom severity in regular users.
  • The genuine exception: in a subgroup of marathon runners, skiers, and soldiers on subarctic exercises exposed to brief, severe physical and cold stress, vitamin C cut cold incidence roughly in half (RR ~0.48–0.50) across multiple trials, at doses that were not unusually high (0.25–1.0g/day).
🩸
Iron Absorption Enhancement Strong, Well-Established
One of the most reliable nutrient interactions in nutrition science
  • Vitamin C chemically reduces dietary nonheme iron from its ferric (Fe³⁺) to its ferrous (Fe²⁺) form, substantially increasing how much of it the gut can absorb.
  • This is one of the most consistently replicated findings in human nutrition research, and is the basis for the common advice to pair iron-rich plant foods or supplements with a vitamin C source.
  • Worth flagging: the same logic does not extend to other minerals — see the Interactions section for why the popular "vitamin C boosts zinc and calcium absorption too" claim does not hold up.
🩹
Collagen Synthesis & Skin / Wound Healing Strong, Mechanistic
The original deficiency disease is a collagen disorder
  • Vitamin C is a required cofactor for prolyl and lysyl hydroxylase, the enzymes that chemically stabilize collagen's triple-helix structure during synthesis.
  • Without adequate vitamin C, collagen secretion decreases and undergoes faster degradation — the direct biochemical basis of scurvy's connective tissue and wound-healing symptoms.
  • This mechanism underlies vitamin C's inclusion in most wound-care and post-surgical nutrition protocols, independent of any antioxidant effect.
⚗️
Antioxidant & Oxidative Stress Defense Real, But Dose-Capped
The effect has a ceiling most labels don't mention
  • As a water-soluble antioxidant, vitamin C directly scavenges reactive oxygen and nitrogen species in blood plasma and other aqueous compartments of the body.
  • Smokers have measurably higher oxidative turnover of vitamin C, which is why official guidance sets their requirement 35mg/day higher than non-smokers'.
  • The catch: because oral absorption saturates at modest doses (see the Absorption Guide), megadosing for "more antioxidant protection" does not meaningfully raise plasma or tissue levels beyond a defined ceiling in people who are not deficient.
💉
High-Dose IV Therapy (Cancer & Sepsis) Genuinely Unresolved
Experimental, contested, and the subject of an active scientific debate
  • Intravenous administration bypasses the gut's absorption ceiling entirely, reaching plasma concentrations 30–70 times higher than any oral dose can achieve — high enough to flip vitamin C's chemistry from antioxidant to pro-oxidant (see Mechanisms). [6]
  • For sepsis specifically, the landmark LOVIT trial found high-dose IV vitamin C associated with a higher risk of death or organ dysfunction, [7] while a meta-analysis of 41 trials (4,915 patients) including LOVIT leaned toward a survival benefit [9] — a genuine, unresolved contradiction in the literature, detailed in Clinical Indications below.
  • For cancer, high-dose IV vitamin C remains experimental and is not an FDA-approved cancer treatment; it requires G6PD-deficiency screening beforehand due to a real, dose-dependent hemolysis risk.
⚡
Carnitine Synthesis Cofactor True, But Contested In Vivo
Textbook fact, with a real asterisk almost nobody mentions
  • Vitamin C is the textbook cofactor for two enzymes (trimethyllysine hydroxylase and γ-butyrobetaine hydroxylase) in the biosynthesis of carnitine, which shuttles fatty acids into mitochondria for energy production. [15]
  • The part rarely mentioned: a 2008 study in genetically vitamin-C-deficient knockout mice found they synthesized carnitine completely normally even when vitamin C-depleted, suggesting glutathione may substitute for ascorbate in this pathway in vivo. [14]
  • So: a real, well-documented cofactor relationship in vitro, but not strictly "essential" for carnitine production the way it's often described.
Clinical Applications

Clinical Indications by Evidence Tier

A deeper, evidence-graded look at the common cold literature and the genuinely contested high-dose IV sepsis debate.

🤧
Common Cold — the Full Cochrane Picture
Three different findings depending on the population
  • General population, prevention: no meaningful effect on the number of people who catch a cold (RR 0.97, 95% CI 0.94–1.00) across more than 10,700 participants. [11]
  • General population, duration/severity: a modest but statistically significant reduction — 8% shorter in adults, 14% shorter in children, with high-dose (1–2g/day) regimens in children shortening colds by 18%. [11]
  • Physical-stress subgroup: in 598 marathon runners, skiers, and soldiers across multiple trials, vitamin C nearly halved cold incidence — a consistent, separately-pooled finding the Cochrane authors describe as distinct from the general-population result, not explained by higher doses. [11]
🔬
High-Dose IV Vitamin C in Sepsis — A Live Scientific Controversy
Presented honestly as unresolved, not settled either way
  • LOVIT (2022, NEJM, n=872): adults with sepsis on vasopressors who received 4-day high-dose IV vitamin C had a significantly higher risk of death or persistent organ dysfunction at 28 days than those who received placebo — a genuine, unexpected harm signal in a well-designed trial. [7]
  • Context that complicates the simple reading: a meta-analysis of 41 randomized trials in severe infection (4,915 patients total, including LOVIT) found low-certainty evidence that vitamin C might instead reduce mortality (RR 0.88), with the effect strengthening when limited to the most rigorously blinded, low-bias trials. [9]
  • The rebound-effect hypothesis: a published secondary analysis of LOVIT found the excess deaths were concentrated specifically in the 3 days immediately after the 4-day vitamin C infusion was stopped (RR 2.28 for that narrow window), arguing this pattern is more consistent with a rebound drop in vitamin C levels after abrupt discontinuation than with ongoing harm from the vitamin C itself — a hypothesis also observed in two other independent sepsis/COVID trials with the same abrupt-stop protocol. [8]
  • Where this leaves things: LOVIT's primary composite outcome (death or persistent organ dysfunction) was statistically significant, but a separate statistical critique points out that among 46 other prespecified secondary outcomes in the same trial, only 3 reached significance — including 28-day all-cause mortality counted on its own. [10] That critique argues that, combined with weak prior evidence for any harmful effect and optimistic power assumptions in the trial's design, the totality of evidence is more consistent with vitamin C having little to no real effect in sepsis than with either a true harm or a true benefit. This is presented here as a genuinely open question, not a resolved one.
Pharmacodynamics

Mechanisms of Action

Vitamin C's reach across collagen, iron, and high-dose IV therapy comes from a small set of distinct chemical actions — including one that flips entirely at very high concentrations.

🪹

Enzymatic Cofactor for Collagen Hydroxylation

Vitamin C is a required cofactor for prolyl 3-hydroxylase, prolyl 4-hydroxylase, and lysyl hydroxylase — the enzymes that hydroxylate proline and lysine residues during collagen synthesis. This hydroxylation step is necessary to form collagen's stable triple-helix structure; without it, procollagen secretion decreases and the protein degrades faster, which is the direct biochemical basis of scurvy's connective-tissue symptoms.

⚗️

Direct Water-Soluble Antioxidant

At physiologic concentrations, vitamin C directly donates electrons to neutralize reactive oxygen and nitrogen species in plasma and other aqueous compartments of the body, and helps regenerate other antioxidants. This is the mechanism behind its role in oxidative-stress defense, and the reason smokers — who have elevated oxidative turnover — have a higher defined requirement.

🧡

Nonheme Iron Absorption Enhancer

Vitamin C chemically reduces dietary iron from its less-absorbable ferric (Fe³⁺) state to the more readily absorbed ferrous (Fe²⁺) state in the gut. This reduction reaction is independent of vitamin C's antioxidant role and is one of the most robust, consistently replicated nutrient-interaction findings in human nutrition science.

🔬

Dual Redox Behavior: Antioxidant at Low Concentrations, Pro-Oxidant at Pharmacologic (IV) Concentrations

At the plasma concentrations achievable by mouth (roughly 70–85µM), vitamin C behaves as an antioxidant. At the much higher millimolar concentrations only achievable by IV infusion, it instead generates hydrogen peroxide as a byproduct of cycling between its ionized and radical forms — a pro-oxidant effect shown in laboratory research to selectively damage some cancer cell lines, [5] and the same mechanism responsible for the hemolysis risk in G6PD-deficient patients discussed in Safety below. This concentration-dependent flip is the central reason oral and IV vitamin C cannot be treated as the same intervention.

⚡

Carnitine Biosynthesis Cofactor (In Vitro)

Vitamin C is the textbook cofactor for trimethyllysine hydroxylase and γ-butyrobetaine hydroxylase, two enzymes in the pathway that builds carnitine from the amino acids lysine and methionine. As noted in Benefits above, in vivo knockout-mouse research has since questioned whether this cofactor role is strictly essential, since carnitine synthesis proceeded normally even under vitamin C depletion — a real biochemical relationship whose practical necessity in living organisms remains genuinely debated.

Clinical Protocols

Dosage & Timing

The IV protocols below are included for clinical-reference completeness only; they are hospital-administered under medical supervision, never self-directed.

Goal Typical Dose Timing / Notes Evidence Base
General RDA (adult men) 90 mg/day With or without food NIH ODS / Institute of Medicine
General RDA (adult women) 75 mg/day With or without food NIH ODS / Institute of Medicine
Smokers RDA + 35 mg/day Reflects elevated oxidative turnover NIH ODS
Common cold duration/severity 1,000–2,000 mg/day, regular use Ongoing supplementation, not just at onset of symptoms Cochrane systematic review
Physical-stress cold prevention 250–1,000 mg/day Started before brief severe physical/cold exposure Cochrane subgroup trials
IV sepsis protocol (hospital only) 50 mg/kg IV every 6h for up to 96h Medical supervision only; this is the LOVIT trial protocol, not a self-administered dose LOVIT trial [7]
IV oncology protocols (hospital only) Typically 25–100g per infusion, varies by protocol Medical supervision only; requires G6PD screening beforehand Oncology trial protocols [5]
Practical single-dose ceiling ~200 mg per dose Split larger daily totals across 2–3 doses for better total absorption Levine et al., PNAS 1996
Tolerable Upper Intake Level 2,000 mg/day Above this, osmotic diarrhea and GI distress become likely Institute of Medicine DRI

Should I split my dose?

Yes, if your total daily target is above roughly 200–500mg. Because absorption efficiency declines as each single dose climbs, taking the same daily total in two or three smaller doses results in more vitamin C actually entering the bloodstream than one large dose taken all at once.

Is more always better for immunity?

No. Above the point where tissues and plasma are already saturated, additional vitamin C is simply excreted in urine rather than providing additional antioxidant benefit. The original PNAS pharmacokinetic study concluded doses above roughly 400mg/day showed no demonstrated added value in healthy, non-deficient people. [1]

The Part Almost No Label Explains

Absorption Guide: The Oral Ceiling

Vitamin C's oral absorption is not linear with dose. A landmark NIH-funded study mapped this curve precisely, and it changes how a "high dose" should actually be thought about.

A single 200mg dose is absorbed almost completely. A single 1,250mg dose is not.

In a National Institutes of Health depletion-repletion study, seven healthy adults were hospitalized for 4–6 months on a vitamin C-depleted diet, then given steady-state doses from 30 to 2,500mg/day while researchers measured plasma, cellular, and urinary vitamin C directly. Both intestinal absorption and kidney reabsorption of vitamin C turned out to be saturable processes — meaning the fraction actually retained by the body falls as the dose rises. [1]

Single Dose Oral Absorption What Happens
Up to ~200 mg ~100% (complete) Fully absorbed; plasma and white blood cell vitamin C reach near-maximal saturation around this range
~500 mg Declining A smaller fraction of each additional milligram is absorbed as intestinal transporters approach saturation
1,250 mg+ Significantly reduced Most of the dose is not absorbed or is rapidly excreted in urine via saturable renal reabsorption
Intravenous (any dose) ~100% (bypasses gut entirely) Can reach plasma concentrations 30–70 times higher than the oral maximum — hospital/prescription use only

This is the direct explanation for why splitting a high daily total into smaller doses absorbs more total vitamin C than one large dose, and why IV administration is not simply "a faster version" of an oral supplement — it is the only route that bypasses this absorption ceiling at all. [6]

Pharmacology

Nutrient & Drug Interactions

A breakdown of vitamin C's confirmed interactions with nutrients, drugs, and lab tests — including several that rarely get explained in plain language.

Interaction Verdict What the Evidence Shows
Nonheme iron Confirmed Synergy Vitamin C reduces dietary iron to its more absorbable ferrous form. One of the most robust, repeatedly confirmed nutrient interactions in human nutrition research.
Zinc absorption Overstated Often marketed alongside the iron claim, but direct comparisons describe vitamin C's effect on zinc absorption as minimal; the two essentially do not meaningfully interfere with or enhance each other.
Calcium absorption Unsupported No strong evidence supports a meaningful calcium-absorption boost from vitamin C, despite this claim circulating alongside the (genuine) iron-absorption effect.
Hemochromatosis / iron overload Caution Because vitamin C increases iron absorption, it can worsen iron overload in people with hemochromatosis or other iron-storage disorders; clinical guidance specifically flags this combination. [24]
Specific chemotherapy agents (vincristine, doxorubicin, methotrexate, cisplatin, imatinib, bortezomib) Caution A major cancer-center pharmacology reference lists vitamin C as potentially reducing the effectiveness of each of these specific agents [24]; more broadly, oncology guidance generally advises against antioxidant supplements during active chemotherapy or radiotherapy because the same free-radical-neutralizing effect that protects healthy cells could in theory also protect tumor cells [23] — though a smaller body of research disputes this and the question remains debated. [25]
Glucose meters & continuous glucose monitors Lab-Assay Artifact High-dose vitamin C can falsely elevate readings on glucose-oxidase or glucose-dehydrogenase test strips; this is severe enough that the NIH Office of Dietary Supplements directly warns about it. [4] Effects are device-specific — see Safety below for details.
Acetaminophen (paracetamol) Caution A major cancer-center drug-interaction reference notes vitamin C may increase acetaminophen's side effects [24]; people taking both regularly should mention this to a healthcare provider.
Safety & Contraindications

Safety & Toxicity Thresholds

🚫

When to Use Caution

  • Kidney stones — men specifically: a prospective cohort of over 23,000 Swedish men found those taking vitamin C supplements at ≥1,000mg/day had a significantly elevated risk of developing kidney stones, not explained by dietary intake. [12] The same elevated risk has not been found in equivalent women's cohort studies, making this a genuinely sex-specific finding rather than a universal risk. [13]
  • GI distress at the Upper Limit: above 2,000mg/day, osmotic diarrhea, nausea, and abdominal cramping become more likely as unabsorbed vitamin C draws water into the gut. [2]
  • Iron overload conditions: because vitamin C enhances iron absorption, people with hemochromatosis or other iron-storage disorders should use caution with supplemental doses.
  • G6PD deficiency, high-dose IV use: very high pharmacologic IV doses can trigger hemolysis in people with this genetic condition, due to the same pro-oxidant chemistry described in Mechanisms; G6PD screening is standard before hospital high-dose IV protocols. [20]
⚠️

Genuinely Unusual Details

  • It can mask dangerously low blood sugar: high-dose vitamin C, oral or IV, can falsely elevate glucose meter readings. A published case report attributes a patient's death to a missed hypoglycemia diagnosis that was masked by a falsely high point-of-care glucose reading after high-dose IV vitamin C. [16]
  • The effect is device-specific, not universal: controlled testing across multiple glucose meter models found vitamin C falsely elevated readings on some devices but not others, depending on the underlying test-strip chemistry (glucose oxidase vs. glucose dehydrogenase-based systems behave differently). [17] A separate evaluation of three hospital-use meters in an oncology patient on high-dose IV vitamin C found two of three devices showed clinically significant false elevation, while the third was specifically designed to correct for ascorbic acid interference. [18] The practical takeaway is the same regardless of device: anyone monitoring blood glucose closely should disclose vitamin C use, oral or IV, to their care team.
  • The G6PD relationship runs in both directions: while very high IV doses can trigger hemolysis in G6PD deficiency, lower IV doses (roughly 1–10g) have separately been used as a treatment for drug-induced hemolysis in G6PD-deficient patients, since methylene blue — the usual antidote — is itself contraindicated in this condition. A 2025 case report also described vitamin C improving red blood cell survival in a milder G6PD variant. [22]
  • Oral megadosing has also been linked to hemolysis, not just IV use, in case reports of prolonged very-high-dose use — a less commonly recognized version of the same underlying mechanism. [19][21]
This page is for educational and professional reference only and does not constitute medical advice, diagnosis, or treatment guidance. High-dose intravenous vitamin C protocols described here require hospital administration and medical supervision, including G6PD screening, and should never be self-directed. People with diabetes who monitor blood glucose, hemochromatosis, a history of kidney stones, G6PD deficiency, or who are undergoing chemotherapy or radiotherapy should speak with a healthcare provider before starting high-dose vitamin C supplementation.
Frequently Asked

FAQ

Does taking more vitamin C than the RDA keep helping, or does it stop at some point?
It stops well before most supplement doses. A landmark NIH depletion-repletion study found a single 200mg dose is essentially completely absorbed, with absorption efficiency declining progressively above that as intestinal transporters saturate. The study's authors concluded doses above roughly 400mg/day showed no demonstrated added value for plasma or tissue saturation in healthy people. Splitting a higher daily total into two or three smaller doses absorbs more total vitamin C than taking it all at once.
Does vitamin C actually prevent or shorten colds?
For most people taking it regularly, it doesn't prevent colds: the Cochrane review found no meaningful reduction in cold incidence across the general population. It did modestly shorten duration (about 8% in adults, 14% in children) and reduce severity. The clear exception is people under brief, severe physical and cold stress — marathon runners, skiers, soldiers on subarctic exercises — where vitamin C cut cold incidence roughly in half across multiple trials.
Can vitamin C supplements cause kidney stones?
In a specific, well-documented subgroup, yes. A prospective cohort of over 23,000 Swedish men found those taking vitamin C supplements at 1,000mg/day or more had a significantly higher risk of kidney stones, not explained by dietary vitamin C. Notably, this elevated risk has not been found in equivalent cohort studies of women. The likely mechanism involves vitamin C's metabolism into oxalate, a major component of the most common stone type.
Can vitamin C interfere with a glucose meter or CGM?
Yes — the NIH Office of Dietary Supplements explicitly warns about this. High-dose vitamin C can falsely elevate readings on certain glucose-oxidase or glucose-dehydrogenase test strips, and case reports describe this masking a dangerously low blood sugar reading. Controlled testing shows the effect is device-specific rather than universal: some glucose meter models show clinically significant false elevation, while others — including some specifically designed to correct for ascorbic acid interference — do not. People monitoring glucose closely should disclose vitamin C use to their care team.
Is high-dose IV vitamin C a real treatment for cancer or sepsis?
It remains genuinely unresolved. For cancer, IV vitamin C reaches concentrations that turn it into a pro-oxidant selectively toxic to some cancer cell lines in laboratory research, but this remains experimental, not an FDA-approved treatment. For sepsis, the large LOVIT trial found high-dose IV vitamin C associated with higher risk of death or organ dysfunction, while a meta-analysis of 41 trials including LOVIT leaned toward a survival benefit, and a secondary analysis argues the apparent harm may reflect a rebound effect from abruptly stopping the infusion rather than direct harm. This is an active, legitimate scientific debate, not a settled question.
Does vitamin C help absorb zinc and calcium the way it helps with iron?
The iron effect is real and well established. The zinc and calcium versions of this claim are not well supported — direct comparisons describe vitamin C's effect on zinc absorption as minimal, with no meaningful interference either way, and there's no strong evidence for a calcium-absorption boost. Only the iron interaction holds up to scrutiny.
Primary Sources

Bibliography

NIH Office of Dietary Supplements, Institute of Medicine Dietary Reference Intakes, PubMed/PMC, and PNAS/NEJM/JAMA for all clinical and regulatory claims. No secondary aggregator was cited as a source for any specific figure.

↑ 1. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A. 1996;93(8):3704–3709. PubMed →
↑ 2. Institute of Medicine (National Academies). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press; 2000. Source for the Tolerable Upper Intake Level and its osmotic-diarrhea basis. NCBI Bookshelf →
↑ 3. NIH Office of Dietary Supplements. Vitamin C — Health Professional Fact Sheet. Source for RDA, UL, and smoker-requirement figures. NIH ODS →
↑ 4. NIH Office of Dietary Supplements. Dietary Supplements for Immune Function and Infectious Diseases (Consumer). Source for the direct glucose-monitor interference warning. NIH ODS →
↑ 5. Chen Q, Espey MG, Krishna MC, et al. Ascorbic acid at pharmacologic concentrations selectively kills cancer cells: ascorbic acid as a pro-drug for hydrogen peroxide delivery to tissues. Proc Natl Acad Sci U S A. 2005;102:13604–13609. PubMed →
↑ 6. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533–537. Source for the 30–70-fold IV-vs-oral plasma concentration difference. PubMed →
↑ 7. Lamontagne F, Masse MH, Menard J, et al. Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit (LOVIT trial). N Engl J Med. 2022;386:2387–2398. NEJM (PubMed) →
↑ 8. Hemilä H. Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial. Eur J Clin Nutr. 2023;77(4):490–494. PubMed →
↑ 9. Putzu A, et al. Restrictive fluid therapy and high-dose vitamin C in sepsis. Nat Med commentary, 2022. Source for the 41-trial, 4,915-patient meta-analysis context. PMC9341155 →
↑ 10. Fooled by Significance Testing: An Analysis of the LOVIT Vitamin C Trial. PMC. Statistical critique noting only 3 of 46 prespecified outcomes were significant. PMC9891468 →
↑ 11. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980. Cochrane Library →
↑ 12. Thomas LD, Elinder CG, Tiselius HG, et al. Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study. JAMA Intern Med. 2013;173(5):386–388. JAMA Network →
↑ 13. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999;10(4):840–845. Contrasting women's-cohort finding referenced in Safety. PubMed →
↑ 14. Furusawa H, Sato Y, Tanaka Y, et al. Vitamin C Is Not Essential for Carnitine Biosynthesis in Vivo: Verification in Vitamin C-Depleted SMP30/GNL Knockout Mice. Biol Pharm Bull. 2008;31(9):1673–1679. PubMed →
↑ 15. Rebouche CJ. Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr. 1991;54(6 Suppl):1147S–1152S. PubMed →
↑ 16. Pseudohyperglycemia Secondary to High-Dose Intravenous Vitamin C Managed as Diabetic Ketoacidosis: An Endocrinological Catastrophe. PMC. Source for the glucose-meter-interference death case report. PMC8282517 →
↑ 17. Influence of Vitamin C and Maltose on the Accuracy of Three Models of Glucose Meters. PMC. PMC4773272 →
↑ 18. Unintended Consequence of High-Dose Vitamin C Therapy for an Oncology Patient: Evaluation of Ascorbic Acid Interference With Three Hospital-Use Glucose Meters. PMC. Source for device-specific interference data. PMC8258510 →
↑ 19. Hemolysis attributed to high dose vitamin C: Two case reports. PubMed. 2024. PubMed →
↑ 20. Is intravenous vitamin C contraindicated in patients with G6PD deficiency? PMC. Source for the low-moderate-dose treatment-of-hemolysis finding. PMC6448313 →
↑ 21. Vitamin C-induced Hemolysis: Meta-summary and Review of Literature. PMC. PMC8857720 →
↑ 22. Self-administered vitamin C increased red blood cell survival in a case of class A G6PD deficiency. Blood Red Cells & Iron, ASH Publications. 2025. ASH Publications →
↑ 23. D'Andrea GM. Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided. CA Cancer J Clin. 2005;55(5):319–321. Wiley →
↑ 24. Memorial Sloan Kettering Cancer Center. Vitamin C — About Herbs Database. Source for the specific chemotherapy-agent and acetaminophen interaction listings, and the hemochromatosis caution. MSK About Herbs →
↑ 25. Simone CB 2nd, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 1. Altern Ther Health Med. 2007;13(1):22–28. Presented for balance against ref. 23. PubMed →
↑ 26. Vitamin C: From Self-Sufficiency to Dietary Dependence in the Framework of Its Biological Functions and Medical Implications. PMC (MDPI). 2025. Source for the GULO gene / endogenous synthesis loss discussion. PMC11856994 →

Related

  • Zinc — another immune-support nutrient with its own dose-dependent absorption and toxicity ceiling, often marketed alongside vitamin C
  • NAC — another antioxidant precursor compound whose oral bioavailability is far lower than most consumers assume, and which shares vitamin C's lab-test-interference theme